ARTICLE | Clinical News
Verigene C regulatory update
December 17, 2012 8:00 AM UTC
Nanosphere said FDA granted 510(k) clearance for its Verigene C. difficile Test. The in vitro diagnostic detects the toxin A and B gene sequences of Clostridium difficile and identifies the BI/NAP1/02...